Icelandic Medicines Agency

Menu


News

  • 2021

    January, February, March, April

  • 2020

    January, February, March, April, May, June, July, August, September, October, November, December

  • 2019

    January, February, March, April, May, June, July, August, September, October, November, December

  • 2018

    January, February, March, April, May, June, July, August, September, October, November, December

  • 2017

    January, February, March, April, May, June, July, August, September, October, November, December

  • 2016

    January, February, March, April, May, June, July, August, September, October, November, December

  • 2015

    January, February, March, April, May, June, July, August, September, October, November, December

  • 2014

    January, February, March, April, May, June, July, August, September, October, November, December

  • 2013

    January, February, March, April, May, June, July, August, September, October, November, December

  • 2012

    January, February, March, April, May, June, July, August, September, October, November, December

  • 2011

    January, February, March, April, May, June, July, August, September, October, November, December

  • 2010

    January, February, March, April, May, June, July, August, September, October, November, December

  • 2009

    January, February, March, April, May, June, July, August, September, October, November, December

  • 2008

    January, February, March, April, May, June, July, August, September, October, November, December


News: April 2010

Unlimited validity of a marketing authorisation confirmed - 14.4.2010

Directive No 2004/27/EC incorporated into the EEA Agreement

See All


You are here: Home > IMA > Publications > News

ima.is

  • Development
    • Clinical Trials
    • Scientific Advice
  • Licences
    • Marketing Authorisations
    • Conditions for Marketing
    • Other Authorisations / Registrations
    • Guidelines on Translations and Text Processing
    • Other Information
    • Safety features
  • Inspections
    • Pharmacies
    • Manufacturer
    • Wholesalers and Distributors
    • Product Classification
    • Importation by Individuals of Medicinal Products for Personal Use
    • Quality Standards
  • Pharmacovigilance
    • General Information
    • Report an adverse drug reaction
    • Legislation
  • Medical Devices
    • About Medical Devices
    • Medical Device Registration
    • Incident Report for Medical Devices
    • CE Marking
    • Law and regulation on Medical Devices
  • IMA
    • About Icelandic Medicines Agency
    • The Pharmaceutical Committee
    • Quality and Performance
    • Laws and Regulations
    • Fees
    • International relations
    • FAQs
    • Contact Us
    • Links
    • Publications

IMA

  • About Icelandic Medicines Agency
  • The Pharmaceutical Committee
  • Quality and Performance
  • Laws and Regulations
  • Fees
  • International relations
  • FAQs
  • Contact Us
  • Links
  • Publications
    • News
      • 2014
      • 2013
      • 2012
      • 2011
      • 2010
      • 2009
      • 2008
    • Lists
    • Forms
    • Annual Reports
    • Articles and Safety Guidance
    • Statistics

Publications

  • News
    • 2014
    • 2013
    • 2012
    • 2011
    • 2010
    • 2009
    • 2008
  • Lists
  • Forms
  • Annual Reports
  • Articles and Safety Guidance
  • Statistics

Search the website


Efraval

  • Sitemap
  • Contact us
  • Icelandic

    • Icelandic Medicines Agency
      (IMA) Disclaimer and copyright

    Vínlandsleið 14
    113 Reykjavík
    Phone: 520 2100
    Fax: 561 2170
    Kt.: 670900-2740
    [email protected]

  • Telephone Hours

    09:00 - 12:00    
    13:00 - 15:30         

    Monday to Friday

  • Follow us

    • facebook
    • twitter
    • youtube

This website is built with Eplica CMS